Estrogen deficiency and risk of alzheimer's disease in women

American Journal of Epidemiology

Volumn 140, Issue 3, 1994, Pages 256-261

  Paganini hill, Annlia ^a   Henderson, Victor W ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Body weight; Dementia; Estrogens; Menarche; Menopause; Senile; Women

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BODY WEIGHT; CASE CONTROL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; ONSET AGE; ORAL DRUG ADMINISTRATION; PROSPECTIVE STUDY; RISK; SENILE DEMENTIA; SENILITY; UNITED STATES;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; ODDS RATIO; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0028085516     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a117244     Document Type: Article

References (33)

1. Goate A, Chartier-Harlin M-C, Mullan M, et ai. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 1991;349:704-6.
2. Schellenberg GD, Bird TD, Wijsman EM, et al. Genetic linkage evidence for a familial Alzheimer’s disease locus on chromosome 14. Science 1992;258:668-71.
3. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 1993;90:1977-81.
4. Evans DA, Funkenstein HH, Albert MS, et al. Prevalence of Alzheimer’s disease in a community population of older persons. Higher than previously reported. JAMA 1989;262:2551-6.
5. Rocca WA, Amaducci LA, Schoenberg BS. Epidemiology of clinically diagnosed Alzheimer’s disease. Ann Neurol 1986;19:415-24.
6. Aronson MK, Ooi WL, Morgenstern H, et al Women, myocardial infarction, and dementia in the very old. Neurology 1990;40:1102-6.
7. Ross RK, Paganini-Hill A Mack TM, et al. Cardiovascular benefits of estrogen replacement therapy. Am J Obstet Gynecol 1989, 160.1301-6.
8. Meldrum DR, Davidson RI, Tataryn IV, et al. Changes in circulating steroids with aging in postmenopausal women. Obstet Gynecol 1981; 57:624-8.
9. Berlinger WG, Potter JF. Low body mass index in demented outpatients. J Am Geriatr Soc 1991; 39:973-8.
10. Lubin JH. Extensions of analytic methods for nested and population-based incident case-control studies. J Chronic Dis 1986;39:379-88.
11. Breslow NE, Day NE, eds. Statistical methods in cancer research. Vol 1. The analysis of case- control studies. Lyon, France: International Agency for Research on Cancer, 1980. (IARC scientific publication no. 32).
12. Broe GA, Henderson AS, Creasey H, et al. A case-control study of Alzheimer’s disease in Australia. Neurology 1990;40:1698-1707.
13. Graves AB, White E, Koepsell TD, et al. A case- control study of Alzheimer’s disease. Ann Neurol 1990;28:766-74.
14. Heyman A, Wilkinson WE, Stafford JA, et al. Alzheimer’s disease: a study of epidemiological aspects. Ann Neurol 1984;15:335-41.
15. Amaducci LA, Fratiglioni L, Rocca WA, et al. Risk factors for clinically diagnosed Alzheimer’s disease: a case-control study of an Italian population. Neurology 1986;36:922-31.
16. Paganini-Hill A, Chao A. Accuracy of recall of hip fracture, heart attack, and cancer: a comparison of postal survey data and medical records. Am J Epidemiol 1993;138:101-6.
17. Bartus RT, Dean RL.III, Beer B, et al. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982;217:408-14.
18. Coyle JT, Price DL, DeLong MR. Alzheimer’s disease: a disorder of cortical cholinergic innervation Science 1983;219:1184-90.
19. Luine VN, Khylchevskaya RI, McEwen B. Effect of gonadal steroids on activities of monoamine oxidase and choline acetylase in rat brain. Brain Res 1975;86:293-306.
20. Luine V, Park D, Joh T, et al. Immunochemical demonstration of increased choline acetyltrans- ferase concentration in rat preoptic area after estradiol administration. Brain Res 1980;191: 273-7.
21. Luine V Estradiol increases choline acetyltrans- ferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol 1985;89:484-90.
22. Bondareff W, Mountjoy CQ, Roth M. Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia Neurology 1982;32:164-8.
23. Bowen DM, Allen SJ, Benton JS, et al. Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer’s disease. J Neurochem 1983;41: 266-72.
24. Cross AJ, Crow TJ, Perry EK, et al. Reduced dopamine-beta-hydroxylase activity in Alzheimer’s disease. Br Med J (Clin Res Ed.) 1981;282:93-4.
25. McEwen BS, Biegon A, Fischetee CT, et al. Towards a neurochemical basis of steroid hormone action. In' Martini L, Ganong W, eds. Frontiers in neuroendocrinology. New York, NY: Raven Press 1984;8 1153-76.
26. Schneider MA, Brotherton PL, Hailes J. The effect of exogenous oestrogens on depression in menopausal women. Med J Aust 1977;2:162-3.
27. Phillips SM, Sherwin BB. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992; 17 485-95.
28. Fedor-Freybergh P. The influence of oestrogen on the well-being and mental performance in climacteric and postmenopausal women. Acta Obstet Gynecol Scand 1977;64:5-69.
29. Campbell S, Whitehead M Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynecol 1977;4: 31-47.
30. Sherwin BB. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 1988;13:345-57.
31. Fillit H, Weinreb H, Cholst I, et al. Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer’s type Psychoneuroendocrinology 1986;11:337-45.
32. Honjo H, Ogino Y, Naitoh K, et al. In vivo effects by estrone sulfate on the central nervous system-senile dementia (Alzheimer’s type). J Steroid Biochem 1989;34:511-15.
33. Henderson VW, Paganini-Hill A, Emanuel CK, et al. Estrogen replacement therapy in older women: comparisons between Alzheimer’s disease cases and non-demented controls. Arch Neurol (In press).